You can receive chemotherapy for pediatric acute leukemia with world-leading treatment outcomes.

Our department includes physicians with four years of clinical training in the United States, enabling smooth communication and consultation in English for pediatric care.

Japanese treatment protocols for pediatric leukemia have demonstrated excellent outcomes internationally, as reported in academic journals, allowing patients to receive both standard and cutting-edge therapies.

We also provide attentive and compassionate nursing care, offering support tailored to both patients and their families.

The hospital is conveniently located, approximately one hour from Komatsu Airport, making it accessible for international patients.

Comprehensive support is available, including assistance with daily life and psychological care.

Providing Medical Institution

Kanazawa Medical University Hospital

〒920-0293
Kahoku-gun Uchinada-machi Daigaku 1-1

https://www.kanazawa-med.ac.jp/~hospital/international/

Specialty

【Health Checkups】

Basic medical examinations

Abdominal ultrasound examination

Gastrointestinal endoscopy

Brain MRI/MRA examination

PET-CT examination

【Treatment】

MRI/Ultrasound fusion-guided prostate biopsy

Gastrointestinal surgical treatment for malignant tumors

Endoscopic surgery for brain tumors

Radiofrequency ablation therapy for peripheral nerves

Total hip replacement surgery

Regenerative therapy for knee joints

Combination chemotherapy for pediatric acute leukemia

Lens reconstruction surgery

Diagnosis and treatment of nephrotic syndrome

Eligibility Criteria/Exclusions for Treatment

Patients requiring hematopoietic stem cell transplantation cannot receive treatment at our hospital. However, we can provide consultation and guidance regarding appropriate treatment facilities.

Remarks

Pediatrics https://www.kanazawa-med.ac.jp/~pediat/ 【Treatment Schedule】 • Examination: approximately 1 week • Hospitalization: approximately 6 months to 1 year • Procedure: central venous catheter insertion • Outpatient treatment and follow-up: approximately 2 years

Precautions / Contraindications

Even if patients meet the above criteria, not all cases can be accepted.
Each case is reviewed internally, and only those deemed suitable are accepted for treatment.